AWM
IDXX icon

Angeles Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Angeles Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733K Buy
1,393
+10
+0.7% +$5.61K 0.03% 204
2026
Q1 		$777K Buy
1,383
+204
+17% +$131K 0.04% 168
2025
Q4 		$798K Sell
1,179
-13
-1% -$8.85K 0.04% 152
2025
Q3 		$762K Buy
1,192
+10
+0.8% +$6.07K 0.05% 146
2025
Q2 		$634K Buy
1,182
+1
+0.1% +$478 0.04% 153
2025
Q1 		$496K Buy
1,181
+1
+0.1% +$434 0.04% 141
2024
Q4 		$488K Buy
1,180
+102
+9% +$44.7K 0.04% 145
2024
Q3 		$545K Buy
1,078
+25
+2% +$12.1K 0.05% 130
2024
Q2 		$513K Buy
1,053
+41
+4% +$20.6K 0.05% 126
2024
Q1 		$546K Buy
1,012
+83
+9% +$45.4K 0.05% 113
2023
Q4 		$516K Sell
929
-71
-7% -$33.3K 0.06% 109
2023
Q3 		$437K Buy
1,000
+1
+0.1% +$499 0.06% 98
2023
Q2 		$502K Hold
999
– – 0.07% 109
2023
Q1 		$500K Sell
999
-7
-0.7% -$3.35K 0.07% 112
2022
Q4 		$410K Buy
1,006
+66
+7% +$25.6K 0.07% 109
2022
Q3 		$306K Sell
940
-14
-1% -$5.14K 0.06% 121
2022
Q2 		$335K Buy
954
+14
+1% +$5.71K 0.07% 123
2022
Q1 		$514K Buy
+940
New +$494K 0.1% 106

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Angeles Wealth Management's IDXX Position: Q2 2026 in Review

Angeles Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.72% in Q2 2026, buying an estimated $5.61K and bringing the position to 1,393 shares worth $733K. The position accounts for 0.03% of the portfolio, ranked #204.

Angeles Wealth Management first reported a position in IDXX in Q1 2022 and has held it in 18 quarters since. The position peaked at $798K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Angeles Wealth Management held 1,393 shares of Idexx Laboratories worth $733K as of Q2 2026.
  • Angeles Wealth Management bought 10 Idexx Laboratories shares in Q2 2026, an estimated $5.61K.
  • Idexx Laboratories made up 0.03% of Angeles Wealth Management's portfolio in Q2 2026, its #204 holding.
  • Angeles Wealth Management first reported a position in Idexx Laboratories in Q1 2022 and has held it in 18 quarters since.
  • Angeles Wealth Management's Idexx Laboratories position peaked at $798K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.